{"name":"Prime Medicine, Inc.","slug":"prime-medicine-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNaGNCZXUxWERHZXhLYVMxOFBMa2MzcE10dXRCeUpfMTZwcEJOYzZ5ZWdtVGRwcVpRU1Y1cUNnY0tFWmFVZXY2VldwQjctSWVnUjF2N08wN21YZVdCNFFNamRRVGFydEFUT0dKN3BCWlE2RnBaSHphZ0RTaFNpWHlWYmZpblM3WmxkZFVNNlF5R0dPMTk5SFkwZE94ZVNjTHp4alhXQ0dvaDZrU21NTTZYOFp3amdzMV9wYWhLamNHMHBGQ2p4bmNWdUFESWNTcVlMZURuVTNOS3FLQm4wQ2xlbEFwU3pjRWEydWpKSERjUGFYX1gwY1RONmFIaGJ0eDZ2ZVItVnRzRXhDZDdOU1JDM1JaRjNJX1ZJcms0LUtwOWo?oc=5","date":"2026-04-07","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Viridian Therapeutics (VRDN) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Viridian Therapeutics (VRDN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNZzU0aHRYbVZmZXNOdlA1a1hYRjgyZUZxSEFzeTBKRWtzcERjeXZfbjZHa1Q2dmszNEhyRzc1NDNhM1FJVFJzZXRQTnlDczlfM3pnTk9ucnRvQkpGUS1seGN2QVVfb29ETDA4RW1QU3lacHF4Mk92MFZnTV9Ba3RVT2h4Rmh2dHd2ZW5SUFhJb1pYWm5uNXFmdTFDaWw4RkNqUjMwX25icVZyQmsxb3lVZWRCSVFOVFR4UGFwQTAyOWNGQ1o5c196WENzTWVwdnZiQlgzTHRfd3BBOW5oQ2x1SExDUkFYemVHdGNLZFlGUjVGRDA4OGc?oc=5","date":"2026-03-31","type":"pipeline","source":"Sahm","summary":"The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step - Sahm","headline":"The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNZVROZm9jVHZrZmV3YlZOYnVSc2hTX2hkdFQ2cU05OV9uV2xqVDNuMjhWU1o1bFoxRGZJUi1oSl81U2ZXRDZVdV9HQmd1Z2NHQW1tVVZVNWJQbW5DSEstSGhIa2x4eDllXzZqbVRuSjA4Z0VUSTZIdnpJSTZ6Sk5ScVljUGgwU0RwWmtVU0V5cjI2NFFqWlBqcGJfYVZUZTJ3S3c?oc=5","date":"2026-03-04","type":"regulatory","source":"BioPharma Dive","summary":"Prime to test FDA flexibility with 2-patient gene editing submission - BioPharma Dive","headline":"Prime to test FDA flexibility with 2-patient gene editing submission","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-31","type":"pipeline","source":"simplywall.st","summary":"Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$110m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st","headline":"Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$110m decrease in market cap last week, although lon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOaUp5b1prN21HeEVpY1FjVGJMcS1HTWF1cnJXYWI3M3VhLTJicV9qblUzWW5fdWY4VEI5RjRZcnBURVl1c1o1Zl84TTdvanRDYjZDUUVLemI0NThIa21BeTNwUXRaYkRKaXlPckpxbVI4c3ZibzkzbndzdHN1XzNpZjNLRFNJSFNIMm83TnZkV2Y0MXJSRjlB?oc=5","date":"2026-01-28","type":"pipeline","source":"BioPharma Dive","summary":"Lilly bets on Seamless, delving further into genetic medicine for hearing loss - BioPharma Dive","headline":"Lilly bets on Seamless, delving further into genetic medicine for hearing loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNdHg0Yk1JMTYtcEJZejJIZmNCTTRZbzFsRGtDemtZUnpwbTRvTDEtbDRvdGNSMGpRTzJIa0hEUF9oeUJ5cEl6ekRZWE9QVlF2U3RJNzlZSnJ1ekpFOWdfWG51LVFaT1pUejJnNU9sR29TMHlFcXZDQTA1Q0VOX3FiZ2FTSjBOUQ?oc=5","date":"2026-01-13","type":"pipeline","source":"Southwest Ledger","summary":"What does the future of gene therapy market hold? - Southwest Ledger","headline":"What does the future of gene therapy market hold?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNEVTNng3TkdFaWY1SlM5Y29meFkxMVZKZE1EQnUzV014Z0o0YWZmMDZtOVFVajhjTzBNM0ZhQUtvdkhpWjVZcThuNUhaSUNOc196NXNSMDhiXzBZN29LdGlWU2RIZ3VVNnBSVUt1cUY4TTJHeURYMmtQUzZGNU9iNEFXVFpOTzRkQ1lNdXBwLU43TldDVjNpZmVYUmRxc1ZVZXRoRHQzYjl1bkk?oc=5","date":"2026-01-02","type":"pipeline","source":"prnewswire.com","summary":"Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize - prnewswire.com","headline":"Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNF8yRVVRdmFIVnN4aUFZOXpLSzhrUU1nZE1Wd241MllMMldSMVROMmduVHJKa1lEZS1kMFQ3MTIzcXhBTVVOR1RCSGZWRk1ZMXFraTRZTmNYODc1dEY4VGdUelUxM0pnWWVwd09LaHpOd0xOUGd3OWZ4eV9JODNWYnVUd1ZkMkZleGd3?oc=5","date":"2025-12-31","type":"pipeline","source":"The Business Journals","summary":"More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals","headline":"More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNNGw5MC1aVjA0ZlVMOUREa2FlY0FDVXMtaEFwUmRFc05nV1N6eWJ2aFdaQUJRZGsxcDZDLTk4ZVpIWHFKSmxENWlnLWpDWkxHNGVobWpKWkRES29rdnZKRzNvVjllN1lUcUtjakoyUmRDTkNRRWVaNHpLSTFwSXNwY0VLN043b25SaDVFaWZvd18zTlItQWJzQWJIZHc5REdZNDJn0gGrAUFVX3lxTE4zd0VKV3NSaWw4MU80VWJaczFiRW1JR1dJaWM2eW1zTW5HZ3QzOVBEMldSTXZHb2ZXdTh5UkJ3VmNfWEdyUHdYVzFzS2lHSUpyMmI1MWVWRVE1TmhpSWY0UkZOYWZ2YUU4dkVYbWZlQXdRTGRMeXNydTFMTkhPbHNFY1hJR01IT0RGb0M2V3lyNHlZbkYwT2J1aTdsZVhnQ3JDcXllMnVzdFBFVQ?oc=5","date":"2025-12-29","type":"deal","source":"Insider Monkey","summary":"10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey","headline":"10 Best Biotech Penny Stocks to Buy According to Analysts","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-09","type":"deal","source":"simplywall.st","summary":"Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying - simplywall.st","headline":"Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9UZ0RlVmtzZnZYVHRVdlNRWnVoaDZvcjJweEoydm9KV2ZtZm0td2V5aU5vS2xyUTk3WGtXeHpnaThBWUY1cWpGcEo2aWpaX3lxN0drOHlVR2xlS2Vp?oc=5","date":"2025-11-14","type":"pipeline","source":"Finimize","summary":"Prime Medicine Bets On Gene Editing’s Next Big Leap - Finimize","headline":"Prime Medicine Bets On Gene Editing’s Next Big Leap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNc1ZybXNqVnFxUGhoQ2dNVEtwQUpjVF9ybWpfazI0RWtzaFlYelczby16RU9nVHlKR1Y1S1dzMF9VdXNnMDBtQnJJWGJlOHJ3N1JQajI1aHlqQVo1czhxVEdyM01qNE5lXzJYTmVnWnNWOHVtZEVpSGliLUJZMlJyYkJLVzNjUWo3YWE1b21SNEIwYVJqZThlcDNfM3EwRV9qUWFlcGhsZVQ2WWJ1UURkcldjU0MzdE45?oc=5","date":"2025-09-22","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Data, Big Name Investors Drive Prime Medicine Stock Surge - Genetic Engineering and Biotechnology News","headline":"StockWatch: Data, Big Name Investors Drive Prime Medicine Stock Surge","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}